Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 28 (22) , 115734
Abstract
No abstract availableKeywords
Funding Information
- Cure Alzheimer's Fund
- National Institute of Neurological Disorders and Stroke
This publication has 42 references indexed in Scilit:
- First and Second Generation γ-Secretase Modulators (GSMs) Modulate Amyloid-β (Aβ) Peptide Production through Different MechanismsJournal of Biological Chemistry, 2012
- The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's diseaseAlzheimer's Research & Therapy, 2011
- Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's DiseaseNeuron, 2010
- The secretases: enzymes with therapeutic potential in Alzheimer diseaseNature Reviews Neurology, 2010
- A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous systemAnnals of Neurology, 2009
- Amyloid Precursor Protein Trafficking, Processing, and FunctionJournal of Biological Chemistry, 2008
- Reconstitution of γ-secretase activityNature Cell Biology, 2003
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- Condensationsprodukte aus Aldehydammoniak und ketonartigen VerbindungenEuropean Journal of Inorganic Chemistry, 1881